Schweikart K, Guo L, Shuler Z, Abrams R, Chiao ET, Kolaja KL, and Davis M
Toxicol In Vitro 27(20:745-51
Publication Date: December 20, 2012
Product Type: iCell Cardiomyocytes
iCell Cardiomyocytes were used to demonstrate that the acute clinical toxicity of jaspamide, an anti-neoplastic agent, is due to drug-induced cardiotoxicity.
iCell Cardiomyocytes were used to elucidate mechanisms of action of an anti-cancer drug associated with clinical toxicity.